Monday, Cullinan Therapeutics, Inc. (CGEM) announced the appointment of Mary Kay Fenton as Chief Financial Officer, effective April 29.
With thirty years of financial and operational expertise in the biotechnology sector, Fenton has worked in various companies focusing on different disease areas, such as immunology.
Before joining Cullinan Therapeutics, she held roles as Interim Chief Executive Officer and Chief Financial Officer at Talaris Therapeutics, Inc.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.